Cargando…
The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates
Coronavirus disease- 2019 (COVID-19) has rapidly become a major threat to humans due to its high infection rate and deaths caused worldwide. This disease is caused by an RNA virus, Severe Acquired Respiratory Syndrome –Corona Virus-2 (SARS-CoV-2). This class of viruses have a high rate of mutation t...
Autor principal: | Azad, Gajendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848562/ https://www.ncbi.nlm.nih.gov/pubmed/33553784 http://dx.doi.org/10.1016/j.heliyon.2021.e06167 |
Ejemplares similares
-
Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2
por: Azad, Gajendra Kumar
Publicado: (2021) -
Immunoinformatics Study of SARS-CoV-2 Nucleocapsid Phosphoprotein Identifies Promising Epitopes with Mutational Implications
por: Kumar, S., et al.
Publicado: (2023) -
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
por: Dinesh, Dhurvas Chandrasekaran, et al.
Publicado: (2020) -
Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function
por: Boniardi, Irene, et al.
Publicado: (2023) -
Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study
por: Muthumanickam, Sankar, et al.
Publicado: (2021)